In this context, our analysis of RNA-sequencing data from the human pancreatic cancer cell lines PANC1 and MIAPACA2 treated with a designed G4 ligand CM03 revealed downregulation of PAK1, PAK2, PAK4, and PAK6 mRNAs (Figure 4A). Here, PAK1 is linked to pancreatic neoplasm.